CUX2 Gene Early Infantile Epileptic Encephalopathy Type 67 NGS Genetic DNA Test
Comprehensive Genetic Testing for Infantile Epilepsy
The CUX2 Gene Early Infantile Epileptic Encephalopathy Type 67 NGS Genetic DNA Test represents a breakthrough in pediatric neurological diagnostics. This advanced genetic test specifically targets mutations in the CUX2 gene, which have been scientifically linked to Early Infantile Epileptic Encephalopathy Type 67 (EIEE67) – a severe form of epilepsy that manifests in the first months of life. Using state-of-the-art Next-Generation Sequencing technology, our test provides unparalleled accuracy in detecting genetic variants that contribute to this devastating neurological condition.
What Does This Test Measure?
This specialized genetic test focuses on comprehensive analysis of the CUX2 gene, examining:
- Point mutations and single nucleotide variants in the CUX2 gene
- Insertions and deletions that may disrupt normal gene function
- Copy number variations affecting CUX2 gene expression
- Regulatory region mutations that impact gene regulation
- Pathogenic variants associated with EIEE67 development
Who Should Consider This Test?
This genetic test is particularly recommended for infants and young children presenting with:
- Early-onset seizures within the first 6 months of life
- Developmental regression or stagnation
- Abnormal EEG patterns consistent with epileptic encephalopathy
- Family history of infantile epilepsy or neurological disorders
- Unexplained developmental delays with seizure activity
- Resistance to conventional anti-epileptic medications
- Progressive neurological deterioration in infancy
Clinical Benefits of CUX2 Genetic Testing
Undergoing CUX2 gene testing provides numerous clinical advantages:
- Precise Diagnosis: Eliminates diagnostic uncertainty and provides definitive genetic confirmation
- Personalized Treatment: Enables targeted therapeutic approaches based on specific genetic findings
- Genetic Counseling: Provides families with comprehensive risk assessment and recurrence probability
- Early Intervention: Facilitates timely implementation of appropriate medical and supportive care
- Family Planning: Offers valuable information for future reproductive decisions
- Prognostic Insights: Helps predict disease progression and potential complications
Understanding Your Test Results
Our comprehensive genetic report provides detailed interpretation of your results:
- Positive Result: Indicates the presence of pathogenic CUX2 gene mutations associated with EIEE67, requiring immediate neurological consultation and specialized care planning
- Negative Result: Suggests that CUX2 gene mutations are not detected, though other genetic causes may need investigation
- Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications, requiring ongoing monitoring and potential family studies
- Carrier Status: Determines if individuals carry one copy of a mutated gene without showing symptoms
Test Pricing Information
| Test Description | Price (USD) |
|---|---|
| CUX2 Gene Early Infantile Epileptic Encephalopathy Type 67 NGS Genetic DNA Test – Discount Price | $500 |
| CUX2 Gene Early Infantile Epileptic Encephalopathy Type 67 NGS Genetic DNA Test – Regular Price | $700 |
Test Specifications and Requirements
- Turnaround Time: 3 to 4 Weeks
- Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
- Technology: Next-Generation Sequencing (NGS)
- Specialty: Neurology and Genetics
- Pre-test Requirements: Complete clinical history and genetic counseling session
Nationwide Accessibility
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and neurological specialists ensures comprehensive care coordination regardless of your location.
Take the Next Step Toward Answers
If your child is experiencing symptoms suggestive of Early Infantile Epileptic Encephalopathy or if you have a family history of neurological disorders, don’t wait to seek answers. Our CUX2 genetic test provides the clarity needed to make informed medical decisions and develop effective treatment strategies.
Call us today at +1(267) 388-9828 to schedule your genetic counseling session and arrange testing. Our compassionate team is ready to guide you through every step of the process, from sample collection to result interpretation and beyond.
Early genetic diagnosis can make a significant difference in managing neurological conditions. Trust our expertise in neurological genetics to provide the answers your family deserves.
